İrem Durmaz

688 total citations
30 papers, 561 citations indexed

About

İrem Durmaz is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, İrem Durmaz has authored 30 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Organic Chemistry, 15 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in İrem Durmaz's work include Synthesis and biological activity (13 papers), Click Chemistry and Applications (5 papers) and Synthesis and Characterization of Heterocyclic Compounds (4 papers). İrem Durmaz is often cited by papers focused on Synthesis and biological activity (13 papers), Click Chemistry and Applications (5 papers) and Synthesis and Characterization of Heterocyclic Compounds (4 papers). İrem Durmaz collaborates with scholars based in Türkiye, United States and Italy. İrem Durmaz's co-authors include Rengül Çetin-Atalay, Mine Yarım, Neerja Kaushik‐Basu, Amartya Basu, Ş. Güniz Küçükgüzel, Dinesh Manvar, Sevil Şenkardeş, Erden Banoğlu, Burcu Çalışkan and Birsen Tozkoparan and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

İrem Durmaz

29 papers receiving 551 citations

Peers

İrem Durmaz
Comparison fields: 5 of 82
  • Organic Chemistry 340
  • Molecular Biology 191
  • Oncology 65
  • Computational Theory and Mathematics 44
  • Pharmacology 37
Lutz Preu Germany
Ola I. A. Salem Egypt
G. Chandrasekara Reddy United States
Viswanath Arutla India
Sultan Nacak Baytaş Türkiye
Naval Kapuriya India
Filippo Prencipe Italy
Matthew G. LaPorte United States
Harshwardhan Singh India
Lutz Preu Germany View profile →
Citations per field, relative to İrem Durmaz
İrem Durmaz · 1×
Citations per year, relative to İrem Durmaz
İrem Durmaz · 1×

Countries citing papers authored by İrem Durmaz

Since Specialization
Citations

This map shows the geographic impact of İrem Durmaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by İrem Durmaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites İrem Durmaz more than expected).

Fields of papers citing papers by İrem Durmaz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by İrem Durmaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by İrem Durmaz. The network helps show where İrem Durmaz may publish in the future.

Co-authorship network of co-authors of İrem Durmaz

This figure shows the co-authorship network connecting the top 25 collaborators of İrem Durmaz. A scholar is included among the top collaborators of İrem Durmaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with İrem Durmaz. İrem Durmaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Synthesis and cytotoxicity of novel 6,8,9-trisubstituted purine analogs against liver cancer cells Bioorganic & Medicinal Chemistry Letters İrem Durmaz, Rengül Çetin-Atalay et al. 2
2 Exploration of novel 6,8,9-trisubstituted purine analogues: synthesis, in vitro biological evaluation, and their effect on human cancer cells TURKISH JOURNAL OF CHEMISTRY İrem Durmaz, Rengül Çetin-Atalay et al. 2
3 Targeting Ovarian Cancer with Chalcone Derivatives: Cytotoxicity and Apoptosis Induction in HGSOC Cells Molecules Eleonora Colombo, Daniele Passarella et al. 2
4 Newly synthesized 6-substituted piperazine/phenyl-9-cyclopentyl containing purine nucleobase analogs act as potent anticancer agents and induce apoptosis via inhibiting Src in hepatocellular carcinoma cells RSC Medicinal Chemistry İrem Durmaz, Rengül Çetin-Atalay et al. 1
5 Tetraphenylethylene-Based Photoluminescent Self-Assembled Nanoparticles: Preparation and Biological Evaluation ACS Medicinal Chemistry Letters Eleonora Colombo, Laura Polito et al. 2
6 Aspergillus Carneus metabolite Averufanin induced cell cycle arrest and apoptotic cell death on cancer cell lines via inducing DNA damage Scientific Reports Ferhat Can Özkaya, Weaam Ebrahim et al. 7
7 A small library of chalcones induce liver cancer cell death through Akt phosphorylation inhibition Scientific Reports İrem Durmaz, Michael S. Christodoulou et al. 11
8 Crizotinib and PARP inhibitors act synergistically by triggering apoptosis in high-grade serous ovarian cancer Oncotarget İrem Durmaz, Ingrid Hedenfalk et al. 11
9 Synthesis of Novel Benzothiazole-Piperazine Derivatives and Their Biological Evaluation as Acetylcholinesterase Inhibitors and Cytotoxic Agents Anti-Cancer Agents in Medicinal Chemistry Hayrettin Ozan Gülcan, Tuğba Erçeti̇n et al. 4
10 Novel triazolothiadiazines act as potent anticancer agents in liver cancer cells through Akt and ASK-1 proteins Bioorganic & Medicinal Chemistry İrem Durmaz, Douglas R. Houston et al. 33
11 Liver cancer cells are sensitive to Lanatoside C induced cell death independent of their PTEN status Phytomedicine İrem Durmaz, Tülin Erşahin et al. 33
12 Synthesis and Anticancer Activity Evaluation of Some Benzothiazole-Piperazine Derivatives Anti-Cancer Agents in Medicinal Chemistry İrem Durmaz, Rengül Çetin-Atalay et al. 26
13 Synthesis of novel diflunisal hydrazide–hydrazones as anti-hepatitis C virus agents and hepatocellular carcinoma inhibitors European Journal of Medicinal Chemistry Sevil Şenkardeş, Neerja Kaushik‐Basu et al. 89
14 Cytotoxic activities of some benzothiazole-piperazine derivatives Journal of Enzyme Inhibition and Medicinal Chemistry İrem Durmaz, Rengül Çetin-Atalay et al. 19
15 Synthesis and preliminary mechanistic evaluation of 5-(p-tolyl)-1-(quinolin-2-yl)pyrazole-3-carboxylic acid amides with potent antiproliferative activity on human cancer cell lines European Journal of Medicinal Chemistry Burcu Çalışkan, İrem Durmaz et al. 45
16 Dual functionality of conjugated polymer nanoparticles as an anticancer drug carrier and a fluorescent probe for cell imaging RSC Advances İrem Durmaz, Özlem Ünal et al. 11
17 Cytotoxic Activities of some Novel Benzhydrylpiperazine Derivatives Drug Research Mine Yarım, İrem Durmaz et al. 9
18 A novel thiazolidine compound induces caspase-9 dependent apoptosis in cancer cells Bioorganic & Medicinal Chemistry İrem Durmaz, Daniel Scherman et al. 40
19 Smart Markers for Watershed-Based Cell Segmentation PLoS ONE Can Koyuncu, Salim Arslan et al. 33
20 Synthesis and Cytotoxic Activity of Novel 3-methyl-1-[(4-substitutedpiperazin-1-yl)methyl]-1H-indole Derivatives Arzneimittelforschung Mine Yarım, İrem Durmaz et al. 1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026